Question 1

Does Citadel Advisors own NTLA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 164,712 shares of NTLA (Intellia Therapeutics), worth $2.8M.

Question 2

How many shares of NTLA does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 164,712 shares of NTLA (Intellia Therapeutics).

Question 3

What is Citadel Advisors' NTLA position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' NTLA position is worth $2.8M.

Question 4

Is Citadel Advisors buying or selling NTLA?

Accepted Answer

In Q2 2026, Citadel Advisors reduced its NTLA position by 293,529 shares (-64.1%).

Question 5

When did Citadel Advisors first buy NTLA?

Accepted Answer

Citadel Advisors already held NTLA in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	164,712	-64.1%	$2.8M	0.0%	$16.92	0
2026-Q1	Decreased	458,241	-51.8%	$5.9M	0.0%	$12.82	0
2025-Q4	Increased	950,250	+9076.7%	$8.5M	0.0%	$8.99	44
2025-Q3	Decreased	10,355	-98.5%	$178,831	0.0%	$17.27	0
2025-Q2	Decreased	709,981	-74.3%	$6.7M	0.0%	$9.38	0
2025-Q1	Increased	2.8M	+10.6%	$19.6M	0.0%	$7.11	31
2024-Q4	Increased	2.5M	+152.1%	$29.1M	0.0%	$11.66	46
2024-Q3	Increased	989,439	+29.7%	$20.3M	0.0%	$20.55	36